- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Heart failure
- Meeting Date: September 2021
- Public Summary Document (PSD) September 2021 PBAC Meeting - (PDF 1.2MB)
- Public Summary Document (PSD) September 2021 PBAC Meeting - (Word 356KB)
Dapagliflozin – September 2021
Dapagliflozin (heart failure): Tablet 10 mg; Forxiga®
Last updated
24 December 2021